Robbin Blau
- Oncology top 10%
- HER2/EGFR in Cancer Research 3
- Cancer Risks and Factors 2
- Cancer Treatment and Pharmacology 1
- Lung Cancer Research Studies 1
- Cancer Research top 10%
- Breast Cancer Treatment Studies 4
-
- Estrogen and related hormone effects 4
-
- Monoclonal and Polyclonal Antibodies Research 1
-
- Cell Adhesion Molecules Research 1
- Journals
- Breast Cancer Research and Treatment (3 papers)Journal of Clinical Oncology (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Robbin Blau
7 papers receiving 475 citations
Peers
Comparison fields: 5 of 46
- Oncology 403
- Cancer Research 169
- Pulmonary and Respiratory Medicine 156
- Genetics 107
- Radiology, Nuclear Medicine and Imaging 88
Countries citing papers authored by Robbin Blau
This map shows the geographic impact of Robbin Blau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robbin Blau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robbin Blau more than expected).
Fields of papers citing papers by Robbin Blau
This network shows the impact of papers produced by Robbin Blau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robbin Blau. The network helps show where Robbin Blau may publish in the future.
Co-authorship network
The 5 scholars most cited alongside Robbin Blau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 140 | |
| 2 | 2005 | 134 | |
| 3 | 2004 | 2 | |
| 4 | 2003 | 90 | |
| 5 | 2002 | 10 | |
| 6 | 1999 | 75 | |
| 7 | 1999 | 41 |
About Robbin Blau
Robbin Blau is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Genetics and Complementary and alternative medicine, having authored 7 papers that have together received 492 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Risks and Factors (2 papers), Cell Adhesion Molecules Research (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Cancer Treatment and Pharmacology (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (403 citations), Cancer Research (169 citations), Pulmonary and Respiratory Medicine (156 citations), Genetics (107 citations) and Radiology, Nuclear Medicine and Imaging (88 citations). Robbin Blau has collaborated with scholars based in United States. Frequent co-authors include Elyse E. Lower, Sue C. Heffelfinger, Deborah Bradley, Douglas K. Hawley and Nitin Rohatgi. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Clinical Breast Cancer and Journal of Women s Health & Gender-Based Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.